Your browser doesn't support javascript.
loading
NUP98-HBO1-fusion generates phenotypically and genetically relevant chronic myelomonocytic leukemia pathogenesis.
Hayashi, Yoshihiro; Harada, Yuka; Kagiyama, Yuki; Nishikawa, Sayuri; Ding, Ye; Imagawa, Jun; Shingai, Naoki; Kato, Naoko; Kitaura, Jiro; Hokaiwado, Shintaro; Maemoto, Yuki; Ito, Akihiro; Matsui, Hirotaka; Kitabayashi, Issay; Iwama, Atsushi; Komatsu, Norio; Kitamura, Toshio; Harada, Hironori.
Afiliación
  • Hayashi Y; Laboratory of Oncology, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.
  • Harada Y; Department of Clinical Laboratory Medicine, Bunkyo Gakuin University, Tokyo, Japan.
  • Kagiyama Y; Laboratory of Oncology, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.
  • Nishikawa S; Laboratory of Oncology, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.
  • Ding Y; Division of Oncology and Hematology, Edogawa Hospital, Tokyo, Japan.
  • Imagawa J; Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
  • Shingai N; Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan.
  • Kato N; Division of Cellular Therapy, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Kitaura J; Atopy Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Hokaiwado S; Laboratory of Oncology, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.
  • Maemoto Y; Laboratory of Cell Signaling, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.
  • Ito A; Laboratory of Cell Signaling, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.
  • Matsui H; Department of Molecular Laboratory Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
  • Kitabayashi I; Division of Hematological Malignancy, National Cancer Center Research Institute, Tokyo, Japan; and.
  • Iwama A; Department of Cellular and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Komatsu N; Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan.
  • Kitamura T; Division of Cellular Therapy, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Harada H; Laboratory of Oncology, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.
Blood Adv ; 3(7): 1047-1060, 2019 04 09.
Article en En | MEDLINE | ID: mdl-30944097
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia Mielomonocítica Crónica / Proteínas de Fusión Oncogénica / Proteínas de Complejo Poro Nuclear / Histona Acetiltransferasas Tipo de estudio: Etiology_studies Límite: Animals / Humans Idioma: En Revista: Blood Adv Año: 2019 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia Mielomonocítica Crónica / Proteínas de Fusión Oncogénica / Proteínas de Complejo Poro Nuclear / Histona Acetiltransferasas Tipo de estudio: Etiology_studies Límite: Animals / Humans Idioma: En Revista: Blood Adv Año: 2019 Tipo del documento: Article País de afiliación: Japón